glp-1 intracranial hypertension Metabolic Concepts in Idiopathic and Their Potential for Therapeutic Intervention Use of glucagon-like peptide-1 receptor
Description
2018;13(4):e0194759
Analysis of specific topic This literature review was conducted following the PICO Framework, with details available in Supplementary material 1
These reviews are often referred to as administrative prior authorization requests
Lose 10-15% of your body weight with GLP-1 Weight Loss
Although comparison studies with GLP-1 RA's have been conducted in the past, new doses have since been approved, making it difficult to compare tirzepatide to GLP-1 RA's based on previous studies
